Twist Bioscience Corporation
Income Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $81.5M | $75.3M | $71.5M | $66.9M | $63.7M | $60.2M | $54.2M | $57.3M |
| Cost of Revenue | $46.2M | $44.4M | $42.5M | $42.4M | $41.8M | $41.7M | $29.4M | $31.6M |
| Gross Profit | $35.3M | $30.9M | $29.0M | $24.5M | $21.9M | $18.5M | $24.8M | $25.7M |
| Gross Margin | 43.3% | 41.0% | 40.5% | 36.6% | 34.4% | 30.8% | 45.7% | 44.9% |
| Operating Expenses | ||||||||
| Research & Development | $22.5M | $24.1M | $23.1M | $23.7M | $24.5M | $27.4M | $31.2M | $29.6M |
| SG&A Expense | $56.8M | $55.6M | $52.8M | $47.4M | $46.1M | $54.0M | $42.3M | $54.2M |
| Operating Income | $-88.9M | $-48.9M | $-47.0M | $-50.1M | $-60.8M | $-61.6M | $-44.6M | $-56.9M |
| Operating Margin | -109.2% | -64.9% | -65.7% | -74.9% | -95.4% | -102.4% | -82.3% | -99.2% |
| Interest Expense | — | $0 | $0 | $1.0K | $1.0K | $2.0K | $1.0K | $25.0K |
| Pretax Income | $-85.4M | $-45.1M | $-42.9M | $-46.5M | $-56.8M | $-58.5M | $-41.7M | $-50.8M |
| Income Tax Expense | $191.0K | $345.0K | $120.0K | $-222.0K | $622.0K | $676.0K | $76.0K | $292.0K |
| Net Income | $-85.6M | $-45.5M | $-43.0M | $-46.2M | $-57.4M | $-59.2M | $-41.8M | $-51.1M |
| Net Margin | -105.0% | -60.4% | -60.2% | -69.1% | -90.0% | -98.3% | -77.1% | -89.2% |
| EPS (Basic) | $-1.47 | $-0.79 | $-0.75 | $-0.81 | $-1.01 | $-1.04 | $-0.74 | $-0.92 |
| EPS (Diluted) | $-1.47 | $-0.79 | $-0.75 | $-0.81 | $-1.01 | $-1.04 | $-0.74 | $-0.92 |
| Shares Outstanding (Basic) | 58.1M | 57.8M | 57.5M | 56.9M | 57.0M | 56.8M | 56.4M | 53.9M |
| Shares Outstanding (Diluted) | 58.1M | 57.8M | 57.5M | 56.9M | 57.0M | 56.8M | 56.4M | 53.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |